UnitedHealth stock is trading -18.08% below its average target price of $576.19 after marking a 5.9% during today's morning session. Analysts are giving the Large-Cap Medical Specialities company an average rating of buy and target prices ranging from $460.0 to $675.0 per share.
UnitedHealth's short interest — meaning the percentage of the share float that is being shorted — is lower than average at 0.8%. The stock's short ratio is 1.73. The company's insiders own 0.24% of its outstanding shares, which indicates a strong alignment between management and shareholder interests.
Another number to watch is the company's rate of institutional share ownership, which now stands at 90.3%. In conclusion, we believe there is mixed market sentiment regarding UnitedHealth.
Institutions Invested in UnitedHealth
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2023-12-31 | Vanguard Group Inc | 9% | 83,860,515 | $39,581,743,367 |
| 2023-12-31 | Blackrock Inc. | 8% | 72,376,243 | $34,161,224,461 |
| 2023-12-31 | State Street Corporation | 5% | 45,518,920 | $21,484,702,423 |
| 2023-12-31 | FMR, LLC | 5% | 41,729,708 | $19,696,213,323 |
| 2023-12-31 | Capital World Investors | 3% | 28,862,345 | $13,622,882,387 |
| 2023-12-31 | Price (T.Rowe) Associates Inc | 3% | 25,968,287 | $12,256,901,495 |
| 2023-12-31 | Wellington Management Group, LLP | 3% | 24,392,706 | $11,513,235,149 |
| 2023-12-31 | JP Morgan Chase & Company | 3% | 23,894,926 | $11,278,285,480 |
| 2023-12-31 | Geode Capital Management, LLC | 2% | 18,213,348 | $8,596,609,100 |
| 2023-12-31 | Morgan Stanley | 2% | 16,777,571 | $7,918,929,542 |
